Factors such as rising prevalence of chronic medical conditions in the fields of neurosciences and cardiology, increasing research and development initiatives in the healthcare sector, and technological advancements in the field of medical sciences are responsible for the growth of this market. Increasing demand for personalized medical care and economic development in Asia-Pacific and Latin American countries will fuel the growth of the market in the future. The utilization of the concepts of nanotechnology in the field of medical science, with diagnostic and therapeutic applications is referred to as “nanomedicines”. Nanomedicines are an emerging field with revolutionary future applications in the treatment and diagnosis of chronic diseases.
For Any Queries Get Solutions With A PDF Sample : http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1086
The nanomedical devices and therapeutics market is segmented into two major categories on the basis of applications and geography. The applications market is segmented into six sub-segments namely cardiovascular disorders, central nervous system (CNS) disorders, oncology, infectious diseases, and inflammatory diseases. Nanomedical devices and therapeutics market by geography is segmented into four sub segments – North America, Asia-Pacific, Europe, and the rest of the world.
The North American region held the majority of the market share in 2011, followed by the European region. Furthermore, the Asia-Pacific region is expected to exhibit the fastest growth rate owing to the fast growing economies of nations such as India and China. In the nanomedical devices and therapeutics application market, CNS disorders and oncology markets are the two most rapidly growing segments.
View exclusive Global strategic Business report http://www.transparencymarketresearch.com/nanomedical-devices-therapeutics.html
Some of the market players in this industry are Starpharma Holdings Limited, Abraxis BioScience Inc., Nektar Therapeutics, Flamel Technologies S.A., Arrowhead Research Corp., Par Pharmaceutical Companies Inc., and Crucell N.V.
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Transparency Market Research
90 State Street,
NY – 12207
USA – Canada Toll Free 866-552-3453